1 | L - Antineoplastic and immunomodulating agents | - | - | - | - | [1] 85 85 |
2 | L 44 | - | - | - | - | [1] 96 96 |
3 | L acetyl carnitine | [1] Levocarnitine Levocarnitine | [3] D02030
D02030
,
D02176
,
D04713
| - | - | [1] 13 13 |
4 | L-000124467 | - | - | - | - | [2] 13 13, 46 |
5 | L-000124467 (freebase) | - | - | - | - | [1] 46 46 |
6 | L-000124467-009J (succinat | - | - | - | - | [1] 46 46 |
7 | L-000883191 | - | - | - | - | [1] 46 46 |
8 | L-001069957 | - | - | - | - | [1] 46 46 |
9 | L-123 Ioflupane | - | - | - | - | [1] 6 6 |
10 | L-3-(3,4-Dihydroxyphenyl)alanine | [1] Alanine Alanine | [1] D00012
D00012
| - | - | [1] 6 6 |
11 | L-883191 | - | - | - | - | [1] 46 46 |
12 | L-alanine | [1] Alanine Alanine | [1] D00012
D00012
| - | - | [1] 299 299 |
13 | L-Arg | [1] Arginine Arginine | [1] D02982
D02982
| - | - | [1] 78 78 |
14 | L-ARG+GHRH | [2] Arginine Arginine, Somatorelin | [2] D02982
D02982
,
D08523
| [1] GHRHR GHRHR 💬 | [2] Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬 | [1] 78 78 |
15 | L-Arginin | [1] Arginine Arginine | [1] D02982
D02982
| - | - | [1] 65 65 |
16 | L-Arginin-hydrochlorid-einmolar Fresenius | [1] Arginine Arginine | [1] D02982
D02982
| - | - | [1] 65 65 |
17 | L-arginine | [1] Arginine Arginine | [1] D02982
D02982
| - | - | [3] 46 46, 113, 299 |
18 | L-asparaginase | [1] Asparaginase Escherichia coli Asparaginase Escherichia coli | [1] D02997
D02997
| - | - | [1] 65 65 |
19 | L-Carnitine | [1] Levocarnitine Levocarnitine | [3] D02030
D02030
,
D02176
,
D04713
| - | - | [7] 13 13, 86, 96, 97, 265, 298, 316 |
20 | L-Citrulline and Metformin & L-Citrulline | [2] Citrulline Citrulline, Metformin | [3] D00944
D00944
,
D04966
,
D07706
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 113 113 |
21 | L-Citrulline Malate | [1] Citrulline Citrulline | [1] D07706
D07706
| - | - | [1] 86 86 |
22 | L-CsA | - | - | - | - | [1] 228 228 |
23 | L-DOPA | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
24 | L-Dopa/ MODOPAR | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
25 | L-DOPA/DDCI | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
26 | L-DOPS | [1] Droxidopa Droxidopa | [1] D01277
D01277
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | [14] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 |
27 | L-fucose | [1] Fucose Fucose | - | - | - | [1] 65 65 |
28 | L-Glutamine | [1] L-Glutamine L-Glutamine | [1] D00015
D00015
| - | - | [2] 113 113, 299 |
29 | L-Histidine | [1] Histidine Histidine | [1] D00032
D00032
| - | - | [1] 13 13 |
30 | L-Lactic acid | [2] L-Lactic acid L-Lactic acid, Lactic acid | [1] D00111
D00111
| - | - | [1] 265 265 |
31 | L-leucine | [1] Leucine Leucine | [1] D00030
D00030
| - | - | [1] 284 284 |
32 | L-Lysine N acetylcysteinate | [1] Lysine Lysine | [1] D02304
D02304
| - | - | [1] 299 299 |
33 | L-Lysine N-acetylcysteinate | [1] Lysine Lysine | [1] D02304
D02304
| - | - | [1] 299 299 |
34 | L-Lysine- N-acetylcysteinate | [1] Lysine Lysine | [1] D02304
D02304
| - | - | [1] 299 299 |
35 | L-Lysine-N-acetyl-L-cysteinate | [1] Lysine Lysine | [1] D02304
D02304
| - | - | [1] 299 299 |
36 | L-Lysine-N-acetylcysteinate | [1] Lysine Lysine | [1] D02304
D02304
| - | - | [1] 299 299 |
37 | L-Lysyl-D-Prolyl-L-Threonine Acetate | [2] Acetate Acetate, Threonine | [1] D00041
D00041
| - | - | [1] 97 97 |
38 | L-Lysyl-D-Prolyl-LThreonine acetate, lyophilisate | [1] Acetate Acetate | - | - | - | [1] 97 97 |
39 | L-methionine | [1] Methionine Methionine | [2] D00019
D00019
,
D04983
| - | - | [1] 84 84 |
40 | L-METHIONINE ([11C]METHYL) | [1] Methionine Methionine | [2] D00019
D00019
,
D04983
| - | - | [1] 84 84 |
41 | L-methylfolate | [1] Levomefolic acid Levomefolic acid | [1] D09353
D09353
| - | - | [1] 6 6 |
42 | L-Serine | [1] Serine Serine | [1] D00016
D00016
| - | - | [1] 2 2 |
43 | L-Threo DOPS | [1] Droxidopa Droxidopa | [1] D01277
D01277
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | [14] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 17 17 |
44 | L-tyrosine | [1] Tyrosine Tyrosine | [1] D00022
D00022
| - | - | [2] 6 6, 111 |
45 | L0006CP03A | - | - | - | - | [1] 75 75 |
46 | L01 - Antineoplastic agents | - | - | - | - | [1] 85 85 |
47 | L0122 | - | - | - | - | [1] 279 279 |
48 | L0133 | - | - | - | - | [1] 50 50 |
49 | L01AA03 | - | - | - | - | [1] 28 28 |
50 | L01BA | - | - | - | - | [1] 96 96 |
51 | L01BA01 | - | - | - | - | [2] 46 46, 107 |
52 | L01BB04 | - | - | - | - | [1] 13 13 |
53 | L01X - Other antineoplastic agents | - | - | - | - | [1] 85 85 |
54 | L01X CO2 | - | - | - | - | [1] 46 46 |
55 | L01XC02 | - | - | - | - | [1] 46 46 |
56 | L01XC15 | - | - | - | - | [1] 222 222 |
57 | L01XE - Protein kinase inhibitors | - | - | - | - | [1] 85 85 |
58 | L01XE31 - Nintedanib | [1] Nintedanib Nintedanib | [1] D10481
D10481
| [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 | [34] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 85 85 |
59 | L01XX14 | - | - | - | - | [1] 75 75 |
60 | L03 AB | - | - | - | - | [1] 13 13 |
61 | L03 AB 08 | - | - | - | - | [1] 13 13 |
62 | L03 AB07 | - | - | - | - | [1] 13 13 |
63 | L03AB13 | - | - | - | - | [1] 13 13 |
64 | L04 AB04 | - | - | - | - | [1] 46 46 |
65 | L04041) | - | - | - | - | [1] 46 46 |
66 | L04AA04 - IMMUNOGLOBULINA ANTITIMOCITARIA (DI CONIGLIO) IMMUNOGLOBULINA DI CONIGLIO ANTITIMOCITI UMANI THYMOGLOBULINE | [1] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | [1] 13 13 |
67 | L04AA10 | - | - | - | - | [2] 278 278, 280 |
68 | L04AA11 | - | - | - | - | [1] 46 46 |
69 | L04AA18 | - | - | - | - | [1] 158 158 |
70 | L04AA24 | - | - | - | - | [2] 46 46, 271 |
71 | L04AA25 | - | - | - | - | [1] 62 62 |
72 | L04AA26 | - | - | - | - | [1] 49 49 |
73 | L04AA31 | - | - | - | - | [1] 13 13 |
74 | L04AB01 | - | - | - | - | [2] 46 46, 271 |
75 | L04AB04 | - | - | - | - | [4] 46 46, 107, 160, 271 |
76 | L04AB05 | - | - | - | - | [2] 46 46, 271 |
77 | L04AC06 | - | - | - | - | [2] 44 44, 45 |
78 | L04AC07 | - | - | - | - | [1] 46 46 |
79 | L04AX03 | - | - | - | - | [1] 46 46 |
80 | L606 (Liposomal Treprostinil) Inhalation Solution 51ug | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
81 | L606 Inhalation System | - | - | - | - | [1] 86 86 |
82 | LA | - | - | - | - | [5] 6 6, 13, 75, 76, 222 |
83 | LA294 | - | - | - | - | [1] 49 49 |
84 | LABA/LAMA | - | - | - | - | [1] 299 299 |
85 | LABP-104 250mg | - | - | - | - | [1] 49 49 |
86 | Lacosamide | [1] Lacosamide Lacosamide | [1] D07299
D07299
| [2] SCN3A SCN3A, SCN9A 💬 | [1] Taste transduction Taste transduction 💬 | [3] 2 2, 46, 149 |
87 | Lacryvisc | [1] Carbomer Carbomer | - | - | - | [1] 53 53 |
88 | Lactated Ringer | - | - | - | - | [1] 296 296 |
89 | Lactated Ringers | - | - | - | - | [2] 96 96, 97 |
90 | Lactic acid | [1] Lactic acid Lactic acid | [1] D00111
D00111
| - | - | [2] 265 265, 299 |
91 | Lactic acid producing organisms | [1] Lactic acid Lactic acid | [1] D00111
D00111
| - | - | [1] 299 299 |
92 | Lactizole nebulization | - | - | - | - | [1] 299 299 |
93 | Lactobacillus | [1] Lactobacillus delbrueckii bulgaricus Lactobacillus delbrueckii bulgaricus | - | - | - | [5] 6 6, 46, 51, 97, 299 |
94 | Lactobacillus casei | [1] Lactobacillus casei Lactobacillus casei | [1] D04351
D04351
| - | - | [3] 6 6, 97, 296 |
95 | Lactobacillus casei DG | [1] Lactobacillus casei Lactobacillus casei | [1] D04351
D04351
| - | - | [1] 97 97 |
96 | Lactobacillus casei DG (Enterolactis duo®) | [1] Lactobacillus casei Lactobacillus casei | [1] D04351
D04351
| - | - | [1] 6 6 |
97 | Lactobacillus casei rhamnosus (Lcr35) | [1] Lactobacillus casei Lactobacillus casei | [1] D04351
D04351
| - | - | [1] 296 296 |
98 | Lactobacillus GG | [1] Lactobacillus delbrueckii bulgaricus Lactobacillus delbrueckii bulgaricus | - | - | - | [1] 97 97 |
99 | Lactobacillus plantarum | [1] Lactobacillus plantarum Lactobacillus plantarum | - | - | - | [3] 6 6, 97, 156 |
100 | Lactobacillus plantarum PS128 | [1] Lactobacillus plantarum Lactobacillus plantarum | - | - | - | [1] 6 6 |
101 | LACTOBACILLUS REUTERI | [1] Lactobacillus reuteri Lactobacillus reuteri | - | - | - | [2] 97 97, 299 |
102 | Lactobacillus rhamnosus | [1] Lactobacillus delbrueckii bulgaricus Lactobacillus delbrueckii bulgaricus | - | - | - | [1] 299 299 |
103 | Lactobacillus rhamnosus GG | [1] Lactobacillus delbrueckii bulgaricus Lactobacillus delbrueckii bulgaricus | - | - | - | [1] 299 299 |
104 | Lactobacillus rhamnosus GG ATCC 53103 | [1] Lactobacillus delbrueckii bulgaricus Lactobacillus delbrueckii bulgaricus | - | - | - | [1] 97 97 |
105 | Lactobacillus salivarius | [1] Lactobacillus salivarius Lactobacillus salivarius | - | - | - | [2] 96 96, 97 |
106 | Lactobacillus salivarius UCC118 | [1] Lactobacillus salivarius Lactobacillus salivarius | - | - | - | [2] 96 96, 97 |
107 | Lactobacilus acidophilus & bifidobacterium animalis/lactis | [1] Lactobacillus acidophilus Lactobacillus acidophilus | [1] D04349
D04349
| - | - | [1] 97 97 |
108 | Lactose | [1] Lactose Lactose | [2] D00046
D00046
,
D03226
| - | - | [6] 2 2, 6, 13, 97, 228, 310 |
109 | Lactose in water | [2] Lactose Lactose, Water | [3] D00001
D00001
,
D00046
,
D03226
| - | - | [1] 97 97 |
110 | Lactose monohydrate | [1] Lactose Lactose | [2] D00046
D00046
,
D03226
| - | - | [1] 13 13 |
111 | Lactulose | [1] Lactulose Lactulose | [1] D00352
D00352
| - | - | [3] 13 13, 96, 291 |
112 | Lactulose/Rhamnose solution | [2] Lactulose Lactulose, Rhamnose | [1] D00352
D00352
| - | - | [1] 96 96 |
113 | Ladarixin | [1] Ladarixin Ladarixin | - | - | - | [1] 162 162 |
114 | Lademirsen | - | - | - | - | [1] 218 218 |
115 | Lademirsen (SAR339375) | - | - | - | - | [1] 218 218 |
116 | LADICell | - | - | - | - | [1] 65 65 |
117 | LAM-002A | - | - | - | - | [1] 2 2 |
118 | LAMAZYM | [1] Velmanase alfa Velmanase alfa | [1] D11024
D11024
| [1] MAN2B1 MAN2B1 💬 | [2] Lysosome Lysosome, Other glycan degradation 💬 | [1] 19 19 |
119 | Lamictal | [1] Lamotrigine Lamotrigine | [1] D00354
D00354
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 144 144 |
120 | Lamivudine | [1] Lamivudine Lamivudine | [1] D00353
D00353
| - | - | [7] 2 2, 26, 42, 46, 135, 265, 325 |
121 | Lamivudine (3TC) | [1] Lamivudine Lamivudine | [1] D00353
D00353
| - | - | [1] 325 325 |
122 | Lamivudine/Zidovudine | [2] Lamivudine Lamivudine, Zidovudine | [2] D00353
D00353
,
D00413
| - | - | [1] 265 265 |
123 | Lamotrigin | - | - | - | - | [2] 34 34, 195 |
124 | Lamotrigin actavis | - | - | - | - | [1] 114 114 |
125 | Lamotrigin beta | - | - | - | - | [2] 34 34, 195 |
126 | Lamotrigin ”Nordic Prime 100 mg | - | - | - | - | [1] 114 114 |
127 | Lamotrigin ”Nordic Prime 25 mg | - | - | - | - | [1] 114 114 |
128 | Lamotrigin ”Nordic Prime 50 mg | - | - | - | - | [1] 114 114 |
129 | Lamotrigine | [1] Lamotrigine Lamotrigine | [1] D00354
D00354
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [5] 13 13, 34, 38, 114, 144 |
130 | Lamotrigine - generic product | [1] Lamotrigine Lamotrigine | [1] D00354
D00354
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 38 38 |
131 | Lamotrigine 25Mg Oral Tablet, Extended Release | [1] Lamotrigine Lamotrigine | [1] D00354
D00354
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 114 114 |
132 | Lamotrigine dispers | [1] Lamotrigine Lamotrigine | [1] D00354
D00354
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 34 34 |
133 | Lamotrigine extended release tablets | [1] Lamotrigine Lamotrigine | [1] D00354
D00354
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 13 13 |
134 | Land exercises | - | - | - | - | [1] 46 46 |
135 | LANIFIBRANOR | [1] Lanifibranor Lanifibranor | - | - | - | [1] 51 51 |
136 | Lannacher | - | - | - | - | [1] 298 298 |
137 | Lanraplenib | [1] Lanraplenib Lanraplenib | [1] D11596
D11596
| - | - | [2] 53 53, 222 |
138 | Lanreotide | [1] Lanreotide Lanreotide | - | - | - | [4] 67 67, 73, 85, 298 |
139 | LANREOTIDE ACETATE | [2] Acetate Acetate, Lanreotide | - | - | - | [4] 67 67, 73, 85, 298 |
140 | Lansolprazole | - | - | - | - | [1] 166 166 |
141 | Lansoprazole | [1] Lansoprazole Lansoprazole | [1] D00355
D00355
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [7] 63 63, 71, 85, 98, 166, 222, 299 |
142 | Lansoprazole 30mg | [1] Lansoprazole Lansoprazole | [1] D00355
D00355
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 166 166 |
143 | Lansoprazole, amoxicillin, clarithromycin | [3] Amoxicillin Amoxicillin, Clarithromycin, Lansoprazole | [5] D00229
D00229
,
D00276
,
D00355
,
D02925
,
D07452
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 222 222 |
144 | Lansoprazole, clarithromycin, amoxycillin | [3] Amoxicillin Amoxicillin, Clarithromycin, Lansoprazole | [5] D00229
D00229
,
D00276
,
D00355
,
D02925
,
D07452
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 63 63 |
145 | Lantarel | - | - | - | - | [1] 46 46 |
146 | Lantus 100 units/ml solution for injection in a cartridge | - | - | - | - | [1] 299 299 |
147 | LANTUS*SC 5CAR3ML100UI/ML | [1] Insulin glargine Insulin glargine | [1] D03250
D03250
| [1] INSR INSR 💬 | [22] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 299 299 |
148 | Lantus® 100 Units/ml solution for injection in a vial. Lantus® 100 Units/ml solution for injection in a cartridge. Lantus® 100 Units/ml solution for injection in a pre-filled pen | - | - | - | - | [1] 299 299 |
149 | Lap TAP Bupivacaine/Epinephrine | [2] Bupivacaine Bupivacaine, Epinephrine | [5] D00095
D00095
,
D00996
,
D01450
,
D02149
,
D07552
| [14] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 96 96 |
150 | Lapaquistat | [1] Lapaquistat Lapaquistat | - | - | - | [1] 79 79 |
151 | Lapaquistat acetate and current lipid-lowering treatment | [2] Acetate Acetate, Lapaquistat | - | - | - | [1] 79 79 |
152 | Lapatinib | [1] Lapatinib Lapatinib | [2] D04024
D04024
,
D08108
| [2] EGFR EGFR, ERBB2 💬 | [50] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction 💬 | [3] 34 34, 74, 75 |
153 | Lapine T-Lymphocyte Immune Globulin | [1] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | [4] 62 62, 65, 283, 286 |
154 | LAQUINIMOD | [1] Laquinimod Laquinimod | - | - | - | [4] 8 8, 13, 49, 96 |
155 | Laquinimod 0.3 | [1] Laquinimod Laquinimod | - | - | - | [1] 13 13 |
156 | Laquinimod 0.6 | [1] Laquinimod Laquinimod | - | - | - | [1] 13 13 |
157 | Laquinimod 1.2 | [1] Laquinimod Laquinimod | - | - | - | [1] 13 13 |
158 | Laquinimod Capsulas 0.6 mg | [1] Laquinimod Laquinimod | - | - | - | [1] 13 13 |
159 | Laquinimod Capsules 0.3 mg | [1] Laquinimod Laquinimod | - | - | - | [1] 13 13 |
160 | Laquinimod capsules 0.5 mg | [1] Laquinimod Laquinimod | - | - | - | [2] 8 8, 96 |
161 | Laquinimod Capsules 0.6 mg | [1] Laquinimod Laquinimod | - | - | - | [1] 13 13 |
162 | Laquinimod Cápsulas 0.5 mg | [1] Laquinimod Laquinimod | - | - | - | [1] 96 96 |
163 | Laquinimod Sodium (USAN) | [1] Laquinimod Laquinimod | - | - | - | [1] 13 13 |
164 | Laquinimod Tablets 0.3 mg | [1] Laquinimod Laquinimod | - | - | - | [1] 13 13 |
165 | Large bore (19G) histologic needle biopsy of the mediastinal lymph nodes | - | - | - | - | [1] 84 84 |
166 | Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP | [5] Dapsone Dapsone, Mycophenolate mofetil, Mycophenolic acid, Prednisolone, Triamcinolone | [18] D00385
D00385
,
D00472
,
D00592
,
D00752
,
D00980
,
D00981
,
D00982
,
D00983
,
D00984
,
D00985
,
D01239
,
D01998
,
D02156
,
D03301
,
D05094
,
D05095
,
D05096
,
D06216
| [3] IMPDH1 IMPDH1, IMPDH2, NR3C1 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | [1] 162 162 |
167 | Large Neutral Amino Acid Therapy | - | - | - | - | [1] 240 240 |
168 | Large protein molecule | - | - | - | - | [1] 46 46 |
169 | Lariam | [1] Mefloquine Mefloquine | [1] D04895
D04895
| - | - | [1] 25 25 |
170 | LARONIDASE | [1] Laronidase Laronidase | [1] D04670
D04670
| [1] IDUA IDUA 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [2] 19 19, 256 |
171 | Laronidase ERT | [1] Laronidase Laronidase | [1] D04670
D04670
| [1] IDUA IDUA 💬 | [3] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1] 19 19 |
172 | Lateral transperitoneal LA | - | - | - | - | [1] 75 75 |
173 | Latozinemab | - | - | - | - | [1] 127 127 |
174 | Latrepirdine | [1] Latrepirdine Latrepirdine | [1] D09917
D09917
| [6] ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [22] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 8 8 |
175 | LAU-7b | - | - | - | - | [1] 299 299 |
176 | LAX-101 | [1] LAX-101 LAX-101 | - | - | - | [1] 8 8 |
177 | LB-P6 | - | - | - | - | [1] 46 46 |
178 | LB-P8 | - | - | - | - | [1] 46 46 |
179 | LB03002 | - | - | - | - | [1] 78 78 |
180 | LBAL | - | - | - | - | [1] 46 46 |
181 | LBEC0101 | - | - | - | - | [1] 46 46 |
182 | LC51-0255 | - | - | - | - | [1] 97 97 |
183 | LCI699 | - | - | - | - | [1] 75 75 |
184 | LCI699, 1 mg | - | - | - | - | [1] 75 75 |
185 | LCI699, 10 mg | - | - | - | - | [1] 75 75 |
186 | LCI699, 20 mg | - | - | - | - | [1] 75 75 |
187 | LCI699, 5 mg | - | - | - | - | [1] 75 75 |
188 | LCIG | - | - | - | - | [1] 6 6 |
189 | LCIG (Duodopa) | - | - | - | - | [1] 6 6 |
190 | LCP-Tacro (tacrolimus) | [1] Tacrolimus Tacrolimus | [2] D00107
D00107
,
D08556
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 95 95 |
191 | LCZ696 | - | - | - | - | [1] 58 58 |
192 | LCZ696 100 mg | - | - | - | - | [1] 58 58 |
193 | LCZ696 200 mg | - | - | - | - | [1] 58 58 |
194 | LCZ696 50 mg | - | - | - | - | [1] 58 58 |
195 | LD / BE | - | - | - | - | [1] 6 6 |
196 | LD+DDCI | - | - | - | - | [1] 6 6 |
197 | LD-aminopterin | [1] Aminopterin Aminopterin | - | - | - | [1] 46 46 |
198 | LD-DDCI | - | - | - | - | [1] 6 6 |
199 | LD/CD | - | - | - | - | [1] 6 6 |
200 | LDP-02 | - | - | - | - | [2] 96 96, 97 |
201 | LDT | - | - | - | - | [1] 65 65 |
202 | LEBRIKIZUMAB | [1] Lebrikizumab Lebrikizumab | [1] D09633
D09633
| [1] IL13 IL13 💬 | [8] Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | [1] 85 85 |
203 | Lederspan | - | - | - | - | [1] 107 107 |
204 | Ledertrexate | - | - | - | - | [1] 46 46 |
205 | Ledertrexato | - | - | - | - | [1] 46 46 |
206 | Ledipasvir | [1] Ledipasvir Ledipasvir | [1] D10442
D10442
| - | - | [1] 19 19 |
207 | Ledipasvir/Sofosbuvir | [2] Ledipasvir Ledipasvir, Sofosbuvir | [2] D10366
D10366
,
D10442
| - | - | [1] 19 19 |
208 | Lefamulin | [1] Lefamulin Lefamulin | [1] D11631
D11631
| - | - | [1] 299 299 |
209 | Leflunomide | [1] Leflunomide Leflunomide | [1] D00749
D00749
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [12] 11 11, 40, 46, 49, 53, 66, 107, 162, 224, 270, 271, 300 |
210 | Leflunomide (permitted, not necessary) | [1] Leflunomide Leflunomide | [1] D00749
D00749
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 46 46 |
211 | Leflunomide 10 milligram (MG) | [1] Leflunomide Leflunomide | [1] D00749
D00749
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 46 46 |
212 | Leflunomide 10mg Tab | [1] Leflunomide Leflunomide | [1] D00749
D00749
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 40 40 |
213 | Leflunomide 20 mg Tablets (Geneva Pharmaceutical) | [1] Leflunomide Leflunomide | [1] D00749
D00749
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 46 46 |
214 | Leflunomide 20 mg+prednisone 0.5mg/kg/d | [2] Leflunomide Leflunomide, Prednisone | [2] D00473
D00473
,
D00749
| [2] DHODH DHODH, NR3C1 💬 | [4] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Neuroactive ligand-receptor interaction, Pyrimidine metabolism 💬 | [1] 66 66 |
215 | Leflunomide 20Mg Tab | [1] Leflunomide Leflunomide | [1] D00749
D00749
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 46 46 |
216 | Leflunomide 20mg/d | [1] Leflunomide Leflunomide | [1] D00749
D00749
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 53 53 |
217 | Leflunomide Mylan | [1] Leflunomide Leflunomide | [1] D00749
D00749
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 53 53 |
218 | Leflunomide(LEF) | [1] Leflunomide Leflunomide | [1] D00749
D00749
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 224 224 |
219 | Leflunomide-Sulfasalazine-Hydroxychloroquine | [3] Hydroxychloroquine Hydroxychloroquine, Leflunomide, Sulfasalazine | [3] D00448
D00448
,
D00749
,
D08050
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 46 46 |
220 | Leflunomidum | [1] Leflunomide Leflunomide | [1] D00749
D00749
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [1] 46 46 |
221 | Left ventricular contractile reserve SE | - | - | - | - | [3] 58 58, 86, 215 |
222 | Left ventricular outflow tract gradient SE | - | - | - | - | [3] 58 58, 86, 215 |
223 | Lemtrada | [1] Alemtuzumab Alemtuzumab | [1] D02802
D02802
| [1] CD52 CD52 💬 | - | [2] 13 13, 65 |
224 | LEMTRADA 12 mg Konzentrat zur Herstellung einer Infusionslösung | [1] Alemtuzumab Alemtuzumab | [1] D02802
D02802
| [1] CD52 CD52 💬 | - | [1] 13 13 |
225 | Lenabasum | - | - | - | - | [3] 50 50, 51, 299 |
226 | Lenabasum 20 mg | - | - | - | - | [3] 50 50, 51, 299 |
227 | Lenabasum 20 mg Powder in Capsule | - | - | - | - | [1] 51 51 |
228 | Lenabasum 5 mg | - | - | - | - | [3] 50 50, 51, 299 |
229 | Lenabasum 5 mg Powder in Capsule | - | - | - | - | [1] 51 51 |
230 | Lenabasum 5mg Powder in Capsule | - | - | - | - | [1] 51 51 |
231 | Lenadogene nolparvovec | - | - | - | - | [1] 302 302 |
232 | Lenalidomide | [1] Lenalidomide Lenalidomide | [1] D04687
D04687
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [8] 16 16, 26, 28, 34, 49, 284, 300, 331 |
233 | Lenalidomide 25mg | [1] Lenalidomide Lenalidomide | [1] D04687
D04687
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 |
234 | Lenalidomide and dexamethasone | [2] Dexamethasone Dexamethasone, Lenalidomide | [10] D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
,
D04687
| [2] NR3C1 NR3C1, TNF 💬 | [68] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 16 16 |
235 | Lenalidomide+Dexamethasone | [2] Dexamethasone Dexamethasone, Lenalidomide | [10] D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
,
D04687
| [2] NR3C1 NR3C1, TNF 💬 | [68] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 16 16 |
236 | Lenalidomide, Dexamethasone | [2] Dexamethasone Dexamethasone, Lenalidomide | [10] D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
,
D04687
| [2] NR3C1 NR3C1, TNF 💬 | [68] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 16 16 |
237 | Lenalidomide, Dexamethasone and Cyclophosphamide | [3] Cyclophosphamide Cyclophosphamide, Dexamethasone, Lenalidomide | [12] D00287
D00287
,
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
,
D04687
,
D07760
| [2] NR3C1 NR3C1, TNF 💬 | [68] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 |
238 | Leniolisib | [1] Leniolisib Leniolisib | [1] D11158
D11158
| [3] PIK3CA PIK3CA, PIK3CB, PIK3CD 💬 | [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [2] 53 53, 65 |
239 | Lenogastrim | - | - | - | - | [1] 28 28 |
240 | Lenograstim | [1] Lenograstim Lenograstim | [1] D03247
D03247
| [1] CSF3R CSF3R 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [7] 2 2, 13, 16, 18, 19, 57, 65 |
241 | Lenti-D Drug Product | - | - | - | - | [1] 20 20 |
242 | Lentiviral G1XCGD Gene Therapy | - | - | - | - | [1] 65 65 |
243 | Lentiviral vector containing ABCA4 gene | - | - | - | - | [1] 301 301 |
244 | Lentiviral vector containing MYO7A gene | - | - | - | - | [2] 90 90, 303 |
245 | Lentiviral vector containing the human MY07A gene | - | - | - | - | [2] 90 90, 303 |
246 | Lentiviral Vector Trans-Skip gene modified Autologous Mesoangioblasts | - | - | - | - | [1] 113 113 |
247 | Lentiviral vector transduced CD34+ cells | - | - | - | - | [1] 65 65 |
248 | Lentivirus Alpha-gal A transduced stem cells | - | - | - | - | [1] 19 19 |
249 | Lentivirus-mediated delivery of ARSA to the CNS. | - | - | - | - | [1] 19 19 |
250 | Lenzumestrocel | - | - | - | - | [1] 2 2 |
251 | Leptin | [1] Leptin Leptin | - | - | - | [2] 6 6, 265 |
252 | Leriglitazone | [1] Leriglitazone Leriglitazone | [1] D11603
D11603
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 20 20 |
253 | Lerodalcibep | - | - | - | - | [1] 79 79 |
254 | Letairis | [1] Ambrisentan Ambrisentan | [1] D07077
D07077
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 85 85 |
255 | Letairis 10 mg | [1] Ambrisentan Ambrisentan | [1] D07077
D07077
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 85 85 |
256 | Letairis 5 mg | [1] Ambrisentan Ambrisentan | [1] D07077
D07077
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 85 85 |
257 | Letermovir | [1] Letermovir Letermovir | [1] D10801
D10801
| - | - | [1] 85 85 |
258 | Letrozole | [1] Letrozole Letrozole | [1] D00964
D00964
| [1] CYP19A1 CYP19A1 💬 | [3] Metabolic pathways Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬 | [2] 81 81, 89 |
259 | Leucine | [1] Leucine Leucine | [1] D00030
D00030
| - | - | [11] 5 5, 6, 7, 19, 65, 96, 97, 127, 283, 284, 299 |
260 | Leuco-methylthioninium bis(hydromethanesulfonate) | [1] Methylthioninium Methylthioninium | - | - | - | [1] 127 127 |
261 | Leucovorin | [1] Leucovorin Leucovorin | [3] D01211
D01211
,
D07986
,
D07987
| - | - | [2] 19 19, 46 |
262 | Leukapheresis | - | - | - | - | [5] 49 49, 51, 96, 284, 285 |
263 | Leukine | [1] Sargramostim Sargramostim | [1] D05803
D05803
| [1] CSF2RA CSF2RA 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 229 229 |
264 | Leukopheresis | - | - | - | - | [1] 51 51 |
265 | Leuplin | - | - | - | - | [1] 76 76 |
266 | Leuplin DPS 11.25mg | - | - | - | - | [1] 76 76 |
267 | Leuprolide | [1] Leuprolide Leuprolide | [1] D00989
D00989
| [1] GNRHR GNRHR 💬 | [2] GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [5] 1 1, 2, 3, 51, 76 |
268 | Leuprolide (GnRH agonists) | [2] Gonadorelin Gonadorelin, Leuprolide | [5] D00988
D00988
,
D00989
,
D03267
,
D04361
,
D08027
| [1] GNRHR GNRHR 💬 | [2] GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 |
269 | Leuprolide Acetate (LA) | [2] Acetate Acetate, Leuprolide | [1] D00989
D00989
| [1] GNRHR GNRHR 💬 | [2] GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 |
270 | Leuprolide acetate 11.25 mg | [2] Acetate Acetate, Leuprolide | [1] D00989
D00989
| [1] GNRHR GNRHR 💬 | [2] GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 |
271 | Leuprolide Acetate 3 Month Depot | [2] Acetate Acetate, Leuprolide | [1] D00989
D00989
| [1] GNRHR GNRHR 💬 | [2] GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 |
272 | Leuprolide acetate 30 mg | [2] Acetate Acetate, Leuprolide | [1] D00989
D00989
| [1] GNRHR GNRHR 💬 | [2] GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 |
273 | Leuprolide Acetate 45 mg | [2] Acetate Acetate, Leuprolide | [1] D00989
D00989
| [1] GNRHR GNRHR 💬 | [2] GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 |
274 | Leuprolide acetate depot | [2] Acetate Acetate, Leuprolide | [1] D00989
D00989
| [1] GNRHR GNRHR 💬 | [2] GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 |
275 | Leuprorelin | [1] Leuprolide Leuprolide | [1] D00989
D00989
| [1] GNRHR GNRHR 💬 | [2] GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [2] 1 1, 76 |
276 | Leuprorelin Acetate | [2] Acetate Acetate, Leuprolide | [1] D00989
D00989
| [1] GNRHR GNRHR 💬 | [2] GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [2] 1 1, 76 |
277 | Leuprorelin Acetate 3.75mg Injection | [2] Acetate Acetate, Leuprolide | [1] D00989
D00989
| [1] GNRHR GNRHR 💬 | [2] GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 |
278 | Levact | - | - | - | - | [1] 61 61 |
279 | Levamisole | [1] Levamisole Levamisole | [2] D00750
D00750
,
D08114
| - | - | [3] 60 60, 61, 62 |
280 | Levamisole hydrochloride | [1] Levamisole Levamisole | [2] D00750
D00750
,
D08114
| - | - | [1] 60 60 |
281 | Levamisole+cyclosporin A+Glucocorticoids | [2] Cyclosporine Cyclosporine, Levamisole | [3] D00184
D00184
,
D00750
,
D08114
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 60 60, 62 |
282 | Levaquin | - | - | - | - | [1] 84 84 |
283 | Levemir | [1] Insulin detemir Insulin detemir | [1] D04539
D04539
| [1] INSR INSR 💬 | [22] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 299 299 |
284 | Levemir 100 U/ml solution for injection in a cartridge, Levemir 100 U/ml solution for injection in a pre-filled pen | [1] Insulin detemir Insulin detemir | [1] D04539
D04539
| [1] INSR INSR 💬 | [22] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 299 299 |
285 | Levemir FlexPen | [1] Insulin detemir Insulin detemir | [1] D04539
D04539
| [1] INSR INSR 💬 | [22] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 299 299 |
286 | Levemir insulin | [1] Insulin detemir Insulin detemir | [1] D04539
D04539
| [1] INSR INSR 💬 | [22] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 299 299 |
287 | Levemir Penfill | [1] Insulin detemir Insulin detemir | [1] D04539
D04539
| [1] INSR INSR 💬 | [22] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 299 299 |
288 | Levetiracetam | [1] Levetiracetam Levetiracetam | [1] D00709
D00709
| [1] SV2A SV2A 💬 | [1] ECM-receptor interaction ECM-receptor interaction 💬 | [5] 2 2, 4, 6, 13, 307 |
289 | Levitra | [1] Vardenafil Vardenafil | [3] D02731
D02731
,
D03260
,
D08668
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 13 13, 86 |
290 | Levobupivacaine | [1] Levobupivacaine Levobupivacaine | [2] D01287
D01287
,
D08116
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 46 46 |
291 | Levocarnil | - | - | - | - | [1] 13 13 |
292 | LEVOCARNITINE | [1] Levocarnitine Levocarnitine | [3] D02030
D02030
,
D02176
,
D04713
| - | - | [3] 3 3, 53, 97 |
293 | Levocarnitine propyl hydrochloride | [1] Levocarnitine Levocarnitine | [3] D02030
D02030
,
D02176
,
D04713
| - | - | [1] 97 97 |
294 | Levocetirizina | [1] Levocetirizine Levocetirizine | [1] D07402
D07402
| [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 61 61 |
295 | LEVOCETIRIZINA DICLORIDRATO | [1] Levocetirizine Levocetirizine | [1] D07402
D07402
| [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 61 61 |
296 | Levocitirizina | - | - | - | - | [1] 61 61 |
297 | Levodopa | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [8] 2 2, 4, 6, 17, 90, 140, 164, 201 |
298 | LEVODOPA (DC.IT) (FU) | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
299 | Levodopa (delivered intravenously) | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
300 | Levodopa (drug), intraduodenal administration | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
301 | Levodopa (L-dopa) | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
302 | Levodopa (L-DOPA) + Standard care | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
303 | LEVODOPA (LD) | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
304 | Levodopa / Benserazid | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
305 | LEVODOPA / BENSERAZIDE 200 + 50 MG | [2] Benserazide Benserazide, Levodopa | [2] D00059
D00059
,
D03082
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
306 | Levodopa 100 mg / benserazide 25 mg | [2] Benserazide Benserazide, Levodopa | [2] D00059
D00059
,
D03082
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
307 | Levodopa 100 mg A CAP | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
308 | Levodopa 125 mg A CAP | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
309 | Levodopa 150 mg A CAP | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
310 | Levodopa 25mg/100mg | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
311 | Levodopa 75 mg A CAP | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
312 | Levodopa acute challenge | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
313 | Levodopa and carbidopa | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
314 | Levodopa and carbidopa SC solution | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
315 | Levodopa and carbidopa solution for SC administration | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
316 | Levodopa and decarboxylase inhibitor | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
317 | Levodopa and Domperidone | [2] Domperidone Domperidone, Levodopa | [3] D00059
D00059
,
D01745
,
D07868
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
318 | Levodopa Benserazide Madopar | [2] Benserazide Benserazide, Levodopa | [2] D00059
D00059
,
D03082
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
319 | Levodopa Benserazide Teva Italia | [2] Benserazide Benserazide, Levodopa | [2] D00059
D00059
,
D03082
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
320 | Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
321 | Levodopa carbidopa intestinal gel (LCIG) | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
322 | Levodopa CR (controlled release) | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
323 | Levodopa Cyclops | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
324 | LEVODOPA DC.IT FU | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
325 | Levodopa dispersible | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
326 | Levodopa infusion | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
327 | LEVODOPA INN | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
328 | Levodopa MR | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
329 | Levodopa powder for inhalation | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
330 | Levodopa tablet | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
331 | Levodopa test | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 17 17 |
332 | Levodopa, carbidopa, entacapone | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] D00059
D00059
,
D00558
,
D00781
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
333 | Levodopa, carbidopa, ODM-104 | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
334 | Levodopa, decarboxylase inhibitor and COMT inhibitor | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
335 | Levodopa-4'-Monophosphate | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
336 | Levodopa-Carbidopa | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [2] 6 6, 90 |
337 | Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
338 | Levodopa-carbidopa Immediate Release (LC-IR) Tablets | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
339 | Levodopa-Carbidopa Intestinal Gel | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
340 | Levodopa-Carbidopa Intestinal Gel (LCIG) | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
341 | Levodopa-Carbidopa Multilayer Extended Release Tablet | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
342 | Levodopa-Carbidopa XL tablet (M) | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
343 | Levodopa-carbidopa-entacapone | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] D00059
D00059
,
D00558
,
D00781
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
344 | Levodopa/benserazide | [2] Benserazide Benserazide, Levodopa | [2] D00059
D00059
,
D03082
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
345 | Levodopa/benserazide 100/25 mg | [2] Benserazide Benserazide, Levodopa | [2] D00059
D00059
,
D03082
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
346 | LEVODOPA/BENZERASIDE | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
347 | Levodopa/Benzerazide | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
348 | LEVODOPA/CARBIDOPA | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [2] 6 6, 164 |
349 | Levodopa/Carbidopa (4:1) | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 201 201 |
350 | Levodopa/Carbidopa (LD/CD) | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
351 | Levodopa/Carbidopa (Sinemet) | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
352 | Levodopa/carbidopa 100/25 | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
353 | Levodopa/Carbidopa Hydrate | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
354 | Levodopa/Carbidopa Solution | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
355 | Levodopa/Carbidopa(200mg/50mg) | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
356 | Levodopa/carbidopa/entacapone | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] D00059
D00059
,
D00558
,
D00781
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
357 | Levodopa/DDCI | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
358 | Levodopa/dopa decarboxylase inhibitor | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
359 | Levofloxacin | [1] Levofloxacin Levofloxacin | [2] D00588
D00588
,
D08120
| - | - | [4] 46 46, 53, 84, 299 |
360 | LEVOFLOXACIN HEMIHYDRATE | [1] Levofloxacin Levofloxacin | [2] D00588
D00588
,
D08120
| - | - | [1] 299 299 |
361 | Levofloxacin Kabi | [1] Levofloxacin Levofloxacin | [2] D00588
D00588
,
D08120
| - | - | [1] 299 299 |
362 | Levofolene | [1] Levoleucovorin Levoleucovorin | - | - | - | [1] 13 13 |
363 | LEVOFOLENE 4 MG 30 CPR | [1] Levoleucovorin Levoleucovorin | - | - | - | [1] 13 13 |
364 | Levoketoconazole | [1] Levoketoconazole Levoketoconazole | [1] D10950
D10950
| - | - | [1] 75 75 |
365 | Levoketozonazole | - | - | - | - | [1] 75 75 |
366 | LEVONORGESTREL | [1] Levonorgestrel Levonorgestrel | [1] D00950
D00950
| [1] PGR PGR 💬 | [5] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | [1] 13 13 |
367 | LEVOSIMENDAN | [1] Levosimendan Levosimendan | [1] D04720
D04720
| [2] PDE3A PDE3A, PDE3B 💬 | [11] Apelin signaling pathway Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 2 2 |
368 | Levothyroxine | [1] Levothyroxine Levothyroxine | [2] D01010
D01010
,
D08125
| [2] THRA THRA, THRB 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [3] 49 49, 78, 80 |
369 | Levulan | - | - | - | - | [1] 34 34 |
370 | Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 1 | [1] Aminolevulinic acid Aminolevulinic acid | [2] D02908
D02908
,
D07567
| - | - | [1] 34 34 |
371 | Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 2 | [1] Aminolevulinic acid Aminolevulinic acid | [2] D02908
D02908
,
D07567
| - | - | [1] 34 34 |
372 | Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 3 | [1] Aminolevulinic acid Aminolevulinic acid | [2] D02908
D02908
,
D07567
| - | - | [1] 34 34 |
373 | LFB-IgSC | - | - | - | - | [1] 65 65 |
374 | LFB-R603 | - | - | - | - | [1] 13 13 |
375 | LFB-R603, TGTX1101 | - | - | - | - | [1] 13 13 |
376 | LFG316 | - | - | - | - | [1] 62 62 |
377 | Liatermin | [1] Liatermin Liatermin | [1] D04727
D04727
| - | - | [1] 6 6 |
378 | Liatermin (r-metHuGDNF) | [1] Liatermin Liatermin | [1] D04727
D04727
| - | - | [1] 6 6 |
379 | LIB003 | - | - | - | - | [1] 79 79 |
380 | Liberase Enzyme (Roche) | - | - | - | - | [2] 85 85, 229 |
381 | Licorice | [1] Licorice Licorice | [1] D04365
D04365
| - | - | [1] 53 53 |
382 | Lidocaine | [1] Lidocaine Lidocaine | [3] D00358
D00358
,
D02086
,
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [12] 6 6, 13, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256 |
383 | Lidocaine 1% Injectable Solution | [1] Lidocaine Lidocaine | [3] D00358
D00358
,
D02086
,
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 34 34 |
384 | Lidocaine 2% without vessel constrictor | [1] Lidocaine Lidocaine | [3] D00358
D00358
,
D02086
,
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 51 51 |
385 | Lidocaine Hydrochloride, Injectable | [1] Lidocaine Lidocaine | [3] D00358
D00358
,
D02086
,
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 70 70 |
386 | Lidocaine Injection 2% | [1] Lidocaine Lidocaine | [3] D00358
D00358
,
D02086
,
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 168 168 |
387 | Lidocaine patch 5% | [1] Lidocaine Lidocaine | [3] D00358
D00358
,
D02086
,
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 13 13 |
388 | Lidocaine Releasing Intravesical System - LiRIS® | [1] Lidocaine Lidocaine | [3] D00358
D00358
,
D02086
,
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 226 226 |
389 | Light box ( Litebook company) | - | - | - | - | [1] 6 6 |
390 | Light box (Litebook company) | - | - | - | - | [1] 6 6 |
391 | Lignocaine | [1] Lidocaine Lidocaine | [3] D00358
D00358
,
D02086
,
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 84 84 |
392 | Limaprost | [1] Limaprost Limaprost | [1] D02722
D02722
| [1] PTGER1 PTGER1 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer 💬 | [1] 70 70 |
393 | LimphoStat-B | - | - | - | - | [1] 53 53 |
394 | Linaclotide | [1] Linaclotide Linaclotide | [1] D09355
D09355
| [1] GUCY2C GUCY2C 💬 | [2] Metabolic pathways Metabolic pathways, Purine metabolism 💬 | [2] 6 6, 97 |
395 | Linerixibat | - | - | - | - | [1] 93 93 |
396 | Linerixibat (GSK2330672) 40 mg | - | - | - | - | [1] 93 93 |
397 | Linerixibat (GSK2330672) 45 mg | - | - | - | - | [1] 93 93 |
398 | Linerixibat (GSK2330672) 45mg | - | - | - | - | [1] 93 93 |
399 | Linez | - | - | - | - | [1] 299 299 |
400 | LINEZOLID | [1] Linezolid Linezolid | [1] D00947
D00947
| - | - | [1] 299 299 |
401 | Lingzhi (Ganoderma) | - | - | - | - | [1] 6 6 |
402 | Lingzhi and Sen Miao San | - | - | - | - | [1] 46 46 |
403 | Linoleic acid | [1] Linoleic acid Linoleic acid | - | - | - | [4] 2 2, 5, 13, 299 |
404 | Linoleic acid supplementation | [1] Linoleic acid Linoleic acid | - | - | - | [1] 299 299 |
405 | Linoleic Acid/Oleic Acid | [2] Linoleic acid Linoleic acid, Oleic Acid | [1] D02315
D02315
| - | - | [1] 13 13 |
406 | Linolenic acid | [2] Gamolenic acid Gamolenic acid, alpha-Linolenic acid | [1] D07213
D07213
| - | - | [1] 46 46 |
407 | LINQ device - implantable cardiac monitor - referred to in the application as implantable loop recorder or ILR) | [1] Methamidophos Methamidophos | - | - | - | [1] 28 28 |
408 | Linsitinib | [1] Linsitinib Linsitinib | [1] D09925
D09925
| [1] IGF1R IGF1R 💬 | [29] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, HIF-1 signaling pathway, Hepatocellular carcinoma, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | [1] 232 232 |
409 | Liofen XL | - | - | - | - | [1] 13 13 |
410 | LIORESAL*50CPR 10MG | [1] Baclofen Baclofen | [1] D00241
D00241
| [2] GABBR1 GABBR1, GABBR2 💬 | [7] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 2 2 |
411 | Liothyronine | [1] Liothyronine Liothyronine | [2] D01011
D01011
,
D08128
| [2] THRA THRA, THRB 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [3] 13 13, 210, 212 |
412 | Liothyronine I 131 | [2] Liothyronine Liothyronine, Liothyronine I-131 | [2] D01011
D01011
,
D08128
| [2] THRA THRA, THRB 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [2] 210 210, 212 |
413 | Liothyronine sodium | [1] Liothyronine Liothyronine | [2] D01011
D01011
,
D08128
| [2] THRA THRA, THRB 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [1] 13 13 |
414 | LIPASA | - | - | - | - | [1] 299 299 |
415 | Lipasa ácida lisosómica, esterasa, colesterol (gen humano LIPA), lipasa ácida lisosómica (gen humano LIPA) | - | - | - | - | [1] 19 19 |
416 | LIPASE | - | - | - | - | [2] 298 298, 299 |
417 | Lipase CLEC | - | - | - | - | [1] 299 299 |
418 | LIPASE LIP2 | - | - | - | - | [1] 299 299 |
419 | Lipase Lip2 from Yarrowia lipolytica | - | - | - | - | [1] 299 299 |
420 | Lipid-lowering agents (Artovastatin) | - | - | - | - | [1] 50 50 |
421 | Lipiodol | [1] Ethiodized oil Ethiodized oil | [2] D04082
D04082
,
D04083
| - | - | [1] 280 280 |
422 | Lipiodol® Ultra Fluid with surgical glues | [1] Ethiodized oil Ethiodized oil | [2] D04082
D04082
,
D04083
| - | - | [1] 280 280 |
423 | Lipitor | [1] Atorvastatin Atorvastatin | [3] D00258
D00258
,
D00887
,
D07474
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [3] 51 51, 96, 299 |
424 | Lipitor® | - | - | - | - | [2] 46 46, 53 |
425 | Lipoic acid | [1] Lipoic acid Lipoic acid | [2] D00048
D00048
,
D00086
| - | - | [5] 2 2, 5, 13, 14, 20 |
426 | Lipoic acid (LA) with fish oil and LA without fish oil | [2] Fish oil Fish oil, Lipoic acid | [2] D00048
D00048
,
D00086
| - | - | [1] 13 13 |
427 | Lipoic acid and omega-3 fatty acids | [2] Lipoic acid Lipoic acid, Omega-3 fatty acids | [2] D00048
D00048
,
D00086
| - | - | [1] 13 13 |
428 | Lipoic acid group | [1] Lipoic acid Lipoic acid | [2] D00048
D00048
,
D00086
| - | - | [1] 2 2 |
429 | Lipopolysaccharide | - | - | - | - | [1] 6 6 |
430 | Liposic | - | - | - | - | [1] 53 53 |
431 | Liposomal aerosol cyclosporine | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 |
432 | Liposomal Amikacin | [1] Amikacin Amikacin | [2] D00865
D00865
,
D02543
| - | - | [1] 299 299 |
433 | Liposomal Amikacin (Arikace TM) | [1] Amikacin Amikacin | [2] D00865
D00865
,
D02543
| - | - | [1] 299 299 |
434 | Liposomal Amikacin (Arikace™) | [1] Amikacin Amikacin | [2] D00865
D00865
,
D02543
| - | - | [1] 299 299 |
435 | Liposomal amikacin for inhalation | [1] Amikacin Amikacin | [2] D00865
D00865
,
D02543
| - | - | [1] 299 299 |
436 | Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer. | [1] Amikacin Amikacin | [2] D00865
D00865
,
D02543
| - | - | [1] 299 299 |
437 | Liposomal amphotericin B (Ambisome®) | [1] Amphotericin B Amphotericin B | [1] D00203
D00203
| - | - | [1] 299 299 |
438 | Liposomal bupivacaine | [1] Bupivacaine Bupivacaine | [2] D01450
D01450
,
D07552
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [3] 51 51, 70, 96 |
439 | Liposomal Cyclosporine A | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 |
440 | Liposomal Cyclosporine A 10 mg | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 |
441 | Liposomal Cyclosporine A 5 mg | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 |
442 | Liposomal Doxorubicin | [1] Doxorubicin Doxorubicin | [1] D03899
D03899
| [2] TOP2A TOP2A, TOP2B 💬 | [1] Platinum drug resistance Platinum drug resistance 💬 | [1] 331 331 |
443 | Liposomal T4N5 lotion | - | - | - | - | [1] 159 159 |
444 | Liposome encapsulated BoNT-A | - | - | - | - | [1] 226 226 |
445 | Liposomed polyphenols resveratrol and curcumin | [2] Curcumin Curcumin, Resveratrol | - | - | - | [1] 2 2 |
446 | Liposomes | - | - | - | - | [1] 226 226 |
447 | LIPOSORBER® LA-15 | - | - | - | - | [1] 222 222 |
448 | LIPOSORBER® LA-15 System | - | - | - | - | [1] 222 222 |
449 | Lipoxygenase inhibitor | - | - | - | - | [1] 160 160 |
450 | Liprotamasa | - | - | - | - | [1] 299 299 |
451 | Liprotamase | - | - | - | - | [2] 298 298, 299 |
452 | Liprotamase Powder for Oral Solution | - | - | - | - | [1] 299 299 |
453 | Lipuro | - | - | - | - | [1] 6 6 |
454 | LIQ861 100 µg | - | - | - | - | [1] 86 86 |
455 | LIQ861 106 µg | - | - | - | - | [1] 86 86 |
456 | LIQ861 25 µg | - | - | - | - | [1] 86 86 |
457 | LIQ861 26.5 µg | - | - | - | - | [1] 86 86 |
458 | LIQ861 50 µg | - | - | - | - | [1] 86 86 |
459 | LIQ861 53 µg | - | - | - | - | [1] 86 86 |
460 | LIQ861 75 µg | - | - | - | - | [1] 86 86 |
461 | LIQ861 79.5 µg | - | - | - | - | [1] 86 86 |
462 | LIQ861 Inhaled Treprostinil | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
463 | Liqourice | - | - | - | - | [1] 75 75 |
464 | Liquigen MCT oil | - | - | - | - | [1] 6 6 |
465 | Liquorice | [1] Licorice Licorice | [1] D04365
D04365
| - | - | [1] 83 83 |
466 | Liraglutide | [1] Liraglutide Liraglutide | [1] D06404
D06404
| [1] GLP1R GLP1R 💬 | [3] Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [3] 6 6, 75, 193 |
467 | Lirentelimab | [1] Lirentelimab Lirentelimab | [1] D11906
D11906
| [1] SIGLEC8 SIGLEC8 💬 | - | [1] 98 98 |
468 | Lirentelimab (AK002) | [1] Lirentelimab Lirentelimab | [1] D11906
D11906
| [1] SIGLEC8 SIGLEC8 💬 | - | [1] 98 98 |
469 | LiRIS 400 mg | - | - | - | - | [1] 226 226 |
470 | LiRIS low dose and LiRIS high dose | - | - | - | - | [1] 226 226 |
471 | LiRIS® | - | - | - | - | [1] 226 226 |
472 | LiRIS® 400 mg | - | - | - | - | [1] 226 226 |
473 | Lisdexamfetamine | [1] Lisdexamfetamine Lisdexamfetamine | [1] D08130
D08130
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |
474 | Lisdexamfetamine sulfate | [2] Lisdexamfetamine Lisdexamfetamine, Sulfate ion | [1] D08130
D08130
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |
475 | Lisinopril | [1] Lisinopril Lisinopril | [2] D00362
D00362
,
D08131
| [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [7] 19 19, 46, 49, 66, 67, 113, 222 |
476 | Lisinopril Pills | [1] Lisinopril Lisinopril | [2] D00362
D00362
,
D08131
| [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 49 49 |
477 | Lisinopril, losartan, and atorvastatin | [3] Atorvastatin Atorvastatin, Lisinopril, Losartan | [7] D00258
D00258
,
D00357
,
D00362
,
D00887
,
D07474
,
D08131
,
D08146
| [3] ACE ACE, AGTR1, HMGCR 💬 | [22] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 |
478 | Lisparin | - | - | - | - | [1] 6 6 |
479 | Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field | - | - | - | - | [1] 13 13 |
480 | LISURIDE | [1] Lisuride Lisuride | [2] D01462
D01462
,
D08132
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [2] 6 6, 86 |
481 | Lisuride Hydrogenmaleate | [1] Lisuride Lisuride | [2] D01462
D01462
,
D08132
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
482 | Lisuride Transdermal System | [1] Lisuride Lisuride | [2] D01462
D01462
,
D08132
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
483 | Lisuride TTS | [1] Lisuride Lisuride | [2] D01462
D01462
,
D08132
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
484 | Lisuride TTS 10cm² | [1] Lisuride Lisuride | [2] D01462
D01462
,
D08132
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
485 | Lisuride TTS 20cm² | [1] Lisuride Lisuride | [2] D01462
D01462
,
D08132
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
486 | Lithium | [1] Lithium citrate Lithium citrate | [1] D04749
D04749
| - | - | [5] 2 2, 5, 6, 7, 8 |
487 | Lithium Apogepha | [1] Lithium citrate Lithium citrate | [1] D04749
D04749
| - | - | [1] 2 2 |
488 | LITHIUM CARBONATE | [2] Carbonate ion Carbonate ion, Lithium carbonate | [1] D00801
D00801
| - | - | [6] 2 2, 13, 17, 18, 19, 127 |
489 | LITHIUM CITRATE | [2] Lithium carbonate Lithium carbonate, Lithium citrate | [2] D00801
D00801
,
D04749
| - | - | [1] 2 2 |
490 | Lithium Gluconate (drug) Glyceryl Triacetate GTA (drug) | [1] Triacetin Triacetin | [1] D00384
D00384
| - | - | [1] 307 307 |
491 | Lithiumcarbonaat | - | - | - | - | [1] 2 2 |
492 | Lithiumcarbonaat 400 PCH tabletten | - | - | - | - | [1] 2 2 |
493 | LITIO CARBONATO | - | - | - | - | [2] 2 2, 17 |
494 | LIV-GAMMA SN Inj. | - | - | - | - | [1] 63 63 |
495 | Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules | [1] Lactobacillus delbrueckii bulgaricus Lactobacillus delbrueckii bulgaricus | - | - | - | [1] 6 6 |
496 | Live Hookworm Larvae | - | - | - | - | [1] 13 13 |
497 | Live Necator americanus larvae | - | - | - | - | [1] 13 13 |
498 | Liver biopsy | - | - | - | - | [4] 93 93, 171, 231, 240 |
499 | Liver transplantation | - | - | - | - | [1] 94 94 |
500 | Livoletide | [1] Livoletide Livoletide | - | - | - | [1] 193 193 |
501 | LIXACOL | - | - | - | - | [1] 97 97 |
502 | Lixisenatide | [1] Lixisenatide Lixisenatide | [1] D09729
D09729
| [1] GLP1R GLP1R 💬 | [3] Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 6 6 |
503 | Lixivaptan | [1] Lixivaptan Lixivaptan | [1] D04752
D04752
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
504 | LJN452 | - | - | - | - | [1] 93 93 |
505 | LJN452, 0,01 mg | - | - | - | - | [1] 93 93 |
506 | LJN452, 0,03 mg | - | - | - | - | [1] 93 93 |
507 | LJN452, 0,1 mg | - | - | - | - | [1] 93 93 |
508 | LJP 394 | - | - | - | - | [1] 49 49 |
509 | LJP394 | - | - | - | - | [1] 49 49 |
510 | Lloprost(Ventavis,BAYQ6252, 10 µg/mL) | [1] Iloprost Iloprost | [1] D02721
D02721
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
511 | Lloprost(Ventavis,BAYQ6252, 20 µg/mL) | [1] Iloprost Iloprost | [1] D02721
D02721
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
512 | LMI070 | - | - | - | - | [2] 3 3, 8 |
513 | LMTM | - | - | - | - | [1] 127 127 |
514 | LMTM/TRx0237 | - | - | - | - | [1] 127 127 |
515 | LMWH/Rivaroxaban | [1] Rivaroxaban Rivaroxaban | [1] D07086
D07086
| [1] F10 F10 💬 | [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 75 75 |
516 | LMX 4 Topical Cream | - | - | - | - | [1] 256 256 |
517 | LNP023 | - | - | - | - | [5] 61 61, 62, 66, 109, 222 |
518 | LNP023 HYDROCHLORIDE SALT | - | - | - | - | [1] 62 62 |
519 | LNP1955 | - | - | - | - | [1] 46 46 |
520 | Lo-Ovral Oral Contraceptive Pills | - | - | - | - | [1] 60 60 |
521 | LO2A eye drops | - | - | - | - | [1] 53 53 |
522 | LO4AB04 | - | - | - | - | [1] 46 46 |
523 | Lobivon | - | - | - | - | [1] 167 167 |
524 | LOBIVON*28CPR 5MG | - | - | - | - | [1] 167 167 |
525 | Local Anesthesia (lidocaine hydrochloride) | [1] Lidocaine Lidocaine | [3] D00358
D00358
,
D02086
,
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 6 6 |
526 | Local Trade Name, 2mg | - | - | - | - | [1] 6 6 |
527 | Local Trade Name, 4mg | - | - | - | - | [1] 6 6 |
528 | Local Trade Name, 8mg | - | - | - | - | [1] 6 6 |
529 | Locally approved intravenous contrast medium for contrast enhanced magnetic resonance imaging (MRI) | - | - | - | - | [1] 13 13 |
530 | LODALÈS® | - | - | - | - | [1] 6 6 |
531 | Lodosyn | - | - | - | - | [1] 13 13 |
532 | Lodotra | - | - | - | - | [1] 41 41 |
533 | Lodotra (delayed release prednisolone) | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 |
534 | Lodotra® | - | - | - | - | [1] 46 46 |
535 | Loestrin (norethindrone acetate and ethinyl estradiol) | [4] Acetate Acetate, Estradiol, Ethinylestradiol, Norethisterone | [11] D00105
D00105
,
D00182
,
D00554
,
D00953
,
D01413
,
D01617
,
D01953
,
D04061
,
D04063
,
D04064
,
D04065
| [3] ESR1 ESR1, ESR2, PGR 💬 | [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 299 299 |
536 | Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol) | [4] Acetate Acetate, Estradiol, Ethinylestradiol, Norethisterone | [11] D00105
D00105
,
D00182
,
D00554
,
D00953
,
D01413
,
D01617
,
D01953
,
D04061
,
D04063
,
D04064
,
D04065
| [3] ESR1 ESR1, ESR2, PGR 💬 | [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [2] 46 46, 49 |
537 | Lojuxta | [1] Lomitapide Lomitapide | [1] D09637
D09637
| [1] MTTP MTTP 💬 | [1] Fat digestion and absorption Fat digestion and absorption 💬 | [1] 79 79 |
538 | Lojuxta 10 mg hard capsules | [1] Lomitapide Lomitapide | [1] D09637
D09637
| [1] MTTP MTTP 💬 | [1] Fat digestion and absorption Fat digestion and absorption 💬 | [1] 79 79 |
539 | Lojuxta 20 mg hard capsules | [1] Lomitapide Lomitapide | [1] D09637
D09637
| [1] MTTP MTTP 💬 | [1] Fat digestion and absorption Fat digestion and absorption 💬 | [1] 79 79 |
540 | Lojuxta 5 mg hard capsules | [1] Lomitapide Lomitapide | [1] D09637
D09637
| [1] MTTP MTTP 💬 | [1] Fat digestion and absorption Fat digestion and absorption 💬 | [1] 79 79 |
541 | Lokomat training | - | - | - | - | [1] 13 13 |
542 | Lomecel-B medicinal signaling cells | - | - | - | - | [1] 211 211 |
543 | LOMITAPIDE | [1] Lomitapide Lomitapide | [1] D09637
D09637
| [1] MTTP MTTP 💬 | [1] Fat digestion and absorption Fat digestion and absorption 💬 | [1] 79 79 |
544 | Lomitapide 2mg hard capsules | [1] Lomitapide Lomitapide | [1] D09637
D09637
| [1] MTTP MTTP 💬 | [1] Fat digestion and absorption Fat digestion and absorption 💬 | [1] 79 79 |
545 | Lonafarnib | [1] Lonafarnib Lonafarnib | [1] D04768
D04768
| [2] FNTA FNTA, FNTB 💬 | [1] Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis 💬 | [2] 113 113, 333 |
546 | Lonafarnib, Zoledronic Acid, and Pravastatin | [3] Lonafarnib Lonafarnib, Pravastatin, Zoledronic acid | [7] D00893
D00893
,
D01968
,
D04768
,
D06378
,
D06379
,
D08410
,
D08689
| [4] FDPS FDPS, FNTA, FNTB, HMGCR 💬 | [6] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 333 333 |
547 | LONAPEGSOMATROPIN | [1] Lonapegsomatropin Lonapegsomatropin | [1] D11486
D11486
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
548 | Lonapegsomatropin drug product | [1] Lonapegsomatropin Lonapegsomatropin | [1] D11486
D11486
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
549 | Long term follow up in all patients who received SAR422459 in previous study TDU13583 | - | - | - | - | [1] 301 301 |
550 | Long Term Follow-Up | - | - | - | - | [1] 169 169 |
551 | Long term oxygen therapy | [1] Oxygen Oxygen | [1] D00003
D00003
| - | - | [1] 88 88 |
552 | Long-Acting Growth Hormone (LAGH) | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
553 | Long-acting somatostatin | [1] Somatostatin Somatostatin | [1] D07431
D07431
| [5] SSTR1 SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬 | [4] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 67 67 |
554 | Long-chain n-3 PUFA | - | - | - | - | [1] 46 46 |
555 | Long-circulating liposomal prednisolone | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
556 | Longeveron Mesenchymal Stem Cells | - | - | - | - | [1] 211 211 |
557 | Lonodelestat | - | - | - | - | [1] 299 299 |
558 | LONOTEN | - | - | - | - | [1] 179 179 |
559 | Lopace | - | - | - | - | [1] 19 19 |
560 | Loperamide | [1] Loperamide Loperamide | [3] D00729
D00729
,
D07113
,
D08144
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 13 13, 97 |
561 | Loperamide hydrochloride | [1] Loperamide Loperamide | [3] D00729
D00729
,
D07113
,
D08144
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 97 97 |
562 | Lopinavir | [1] Lopinavir Lopinavir | [1] D01425
D01425
| - | - | [1] 265 265 |
563 | Lopinavir/Ritonavir | [2] Lopinavir Lopinavir, Ritonavir | [2] D00427
D00427
,
D01425
| - | - | [1] 265 265 |
564 | Lopinavir/ritonavir + nevirapine | [3] Lopinavir Lopinavir, Nevirapine, Ritonavir | [3] D00427
D00427
,
D00435
,
D01425
| - | - | [1] 265 265 |
565 | Lopinavir/ritonavir + zidovudine + lamivudine | [4] Lamivudine Lamivudine, Lopinavir, Ritonavir, Zidovudine | [4] D00353
D00353
,
D00413
,
D00427
,
D01425
| - | - | [1] 265 265 |
566 | Loratadina | [1] Loratadine Loratadine | [1] D00364
D00364
| [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 89 89 |
567 | Loratadina Stada | [1] Loratadine Loratadine | [1] D00364
D00364
| [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 89 89 |
568 | Loratadina STADA 10 mg | [1] Loratadine Loratadine | [1] D00364
D00364
| [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 89 89 |
569 | Loratadine | [1] Loratadine Loratadine | [1] D00364
D00364
| [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [4] 13 13, 46, 89, 98 |
570 | Lorazepam | [1] Lorazepam Lorazepam | [1] D00365
D00365
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [2] 36 36, 231 |
571 | Lorcaserin | [1] Lorcaserin Lorcaserin | - | - | - | [1] 140 140 |
572 | Lorenzo's Oil | - | - | - | - | [1] 20 20 |
573 | Lortaan | - | - | - | - | [1] 167 167 |
574 | LORTAAN*28CPR RIV DIV 50MG | - | - | - | - | [1] 167 167 |
575 | Losartan | [1] Losartan Losartan | [2] D00357
D00357
,
D08146
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [18] 17 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
576 | Losartan and Atenolol or Propranolol | [3] Atenolol Atenolol, Losartan, Propranolol | [5] D00235
D00235
,
D00357
,
D00483
,
D08146
,
D08443
| [4] ADRB1 ADRB1, ADRB2, ADRB3, AGTR1 💬 | [23] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 167 167 |
577 | Losartan and nebivolol | [2] Losartan Losartan, Nebivolol | [3] D00357
D00357
,
D05127
,
D08146
| [2] ADRB1 ADRB1, AGTR1 💬 | [22] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 167 167 |
578 | Losartan and other angiotensin receptor blockers | [2] Angiotensin II Angiotensin II, Losartan | [4] D00150
D00150
,
D00357
,
D02014
,
D08146
| [2] AGTR1 AGTR1, AGTR2 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 19 19 |
579 | Losartan Bluefish 50 mg | [2] Bluefish Bluefish, Losartan | [2] D00357
D00357
,
D08146
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 58 58 |
580 | Losartan HEXAL | [1] Losartan Losartan | [2] D00357
D00357
,
D08146
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 36 36 |
581 | LOSARTAN POTASICO | [1] Losartan Losartan | [2] D00357
D00357
,
D08146
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 179 179 |
582 | LOSARTAN POTASSIUM | [2] Losartan Losartan, Potassium | [3] D00357
D00357
,
D08146
,
D08403
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [5] 36 36, 98, 167, 179, 215 |
583 | Losartan Tablets & QingReMoShen Granule | [1] Losartan Losartan | [2] D00357
D00357
,
D08146
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 |
584 | Losec | [1] Omeprazole Omeprazole | [4] D00455
D00455
,
D01207
,
D05259
,
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [3] 46 46, 225, 294 |
585 | Losec Capsules 20 mg | [1] Omeprazole Omeprazole | [4] D00455
D00455
,
D01207
,
D05259
,
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 46 46 |
586 | LOSMAPIMOD | [1] Losmapimod Losmapimod | [1] D09639
D09639
| [4] MAPK11 MAPK11, MAPK12, MAPK13, MAPK14 💬 | [62] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬 | [2] 113 113, 222 |
587 | LOU064 | - | - | - | - | [2] 13 13, 53 |
588 | Lovastatin | [1] Lovastatin Lovastatin | [1] D00359
D00359
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [11] 6 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 |
589 | Lovastatin 60 MG | [1] Lovastatin Lovastatin | [1] D00359
D00359
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 34 34 |
590 | Lovastatin ™ | [1] Lovastatin Lovastatin | [1] D00359
D00359
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 34 34 |
591 | Lovastatin, then Minocycline/Lovastatin | [2] Lovastatin Lovastatin, Minocycline | [3] D00359
D00359
,
D00850
,
D05045
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 206 206 |
592 | Low antigen content diet | - | - | - | - | [1] 66 66 |
593 | Low calorie protein substitute | - | - | - | - | [1] 240 240 |
594 | Low carbohydrate ketogenic diet | - | - | - | - | [1] 256 256 |
595 | Low copper diet | [1] Copper Copper | - | - | - | [1] 171 171 |
596 | Low Dietary Sodium | - | - | - | - | [1] 49 49 |
597 | Low dose | - | - | - | - | [1] 97 97 |
598 | Low dose AFFITOPE® PD03A + Adjuvant | - | - | - | - | [1] 6 6 |
599 | Low dose arm receiving neutral oil and 400 IU/g of Vitamin D every second day | [1] Vitamin D Vitamin D | - | - | - | [1] 13 13 |
600 | Low Dose Aspirin (162 mg/day) | [1] Acetylsalicylic acid Acetylsalicylic acid | [1] D00109
D00109
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 13 13 |
601 | Low dose BIBF 1120 twice daily | - | - | - | - | [1] 85 85 |
602 | Low dose BIBF1120 once daily | - | - | - | - | [1] 85 85 |
603 | Low Dose Budesonide | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
604 | Low dose budesonide tablet | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
605 | Low dose cannabis | [1] Medical Cannabis Medical Cannabis | - | - | - | [1] 13 13 |
606 | Low dose levodopa | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
607 | Low Dose Mesenchymal Stem Cells (MSCs) | - | - | - | - | [1] 49 49 |
608 | Low Dose MT-1303 | - | - | - | - | [1] 97 97 |
609 | Low dose naltrexone | [1] Naltrexone Naltrexone | [2] D02095
D02095
,
D05113
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 96 96, 97 |
610 | Low dose of BIIL 284 BS tablets | - | - | - | - | [1] 46 46 |
611 | Low dose ORTD-1 | - | - | - | - | [1] 46 46 |
612 | Low dose prednisolone | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 84 84 |
613 | Low dose TSO | - | - | - | - | [1] 96 96 |
614 | Low dose vehicle control | - | - | - | - | [1] 46 46 |
615 | Low Dose-VIS649 | - | - | - | - | [1] 66 66 |
616 | Low FODMAP | - | - | - | - | [1] 97 97 |
617 | Low immunogenic interferon-beta-1a | [2] Human interferon beta Human interferon beta, Interferon beta-1a | [1] D04554
D04554
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 |
618 | Low Molecular Weight Heparin Calcium Injection | [2] Calcium Calcium, Heparin | [1] D07510
D07510
| [1] SERPINC1 SERPINC1 💬 | [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 224 224 |
619 | Low Protein and High Fiber Diet | - | - | - | - | [1] 97 97 |
620 | Low Residue Diet Intervention | - | - | - | - | [1] 21 21 |
621 | Low serine diet | [1] Serine Serine | [1] D00016
D00016
| - | - | [1] 96 96 |
622 | Low-dose Aldesleukin (Proleukin®) | [1] Aldesleukin Aldesleukin | [1] D00748
D00748
| [3] IL2RA IL2RA, IL2RB, IL2RG 💬 | [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 49 49 |
623 | Low-dose IL-2 | [1] Human interleukin-2 Human interleukin-2 | - | - | - | [1] 56 56 |
624 | Low-dose IL-2 administration | [1] Human interleukin-2 Human interleukin-2 | - | - | - | [1] 96 96 |
625 | Low-dose naltrexone | [1] Naltrexone Naltrexone | [2] D02095
D02095
,
D05113
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 |
626 | Low-Dose REGN4461 | - | - | - | - | [1] 265 265 |
627 | Low-Frequency-Only Stimulation | - | - | - | - | [1] 6 6 |
628 | Loxoprofen | [1] Loxoprofen Loxoprofen | [1] D08149
D08149
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [2] 46 46, 271 |
629 | Loxoprofen sodium hydrogel patch | [1] Loxoprofen Loxoprofen | [1] D08149
D08149
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 |
630 | Loxoprofen sodium tablet | [1] Loxoprofen Loxoprofen | [1] D08149
D08149
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 |
631 | LP-08 20mg | - | - | - | - | [1] 226 226 |
632 | LP-08 80mg | - | - | - | - | [1] 226 226 |
633 | LPA1 | - | - | - | - | [1] 85 85 |
634 | LPM3770164 sustained release tablet | [1] Manganese citrate Manganese citrate | - | - | - | [1] 8 8 |
635 | LPM3770164 sustained release tablet simulant | [1] Manganese citrate Manganese citrate | - | - | - | [1] 8 8 |
636 | LSD | - | - | - | - | [1] 271 271 |
637 | LT-02 | - | - | - | - | [1] 97 97 |
638 | LT-02 (modified-release PC pellets) | [1] Manganese citrate Manganese citrate | - | - | - | [1] 97 97 |
639 | LT4 | - | - | - | - | [1] 222 222 |
640 | LTP001 | - | - | - | - | [1] 86 86 |
641 | LTS 0.25mg | - | - | - | - | [1] 46 46 |
642 | LTS 0.5mg | - | - | - | - | [1] 46 46 |
643 | LTS 1.0mg | - | - | - | - | [1] 46 46 |
644 | Lu 00-800 | - | - | - | - | [1] 6 6 |
645 | LU 70274 | - | - | - | - | [1] 299 299 |
646 | Lu AA24493 | - | - | - | - | [1] 18 18 |
647 | Lu AF28996 | - | - | - | - | [1] 6 6 |
648 | Lu AF82422 | - | - | - | - | [2] 6 6, 17 |
649 | Lu AG06466 | - | - | - | - | [1] 13 13 |
650 | LUBIPROSTONE | [1] Lubiprostone Lubiprostone | [1] D04790
D04790
| [1] CLCN2 CLCN2 💬 | [1] Mineral absorption Mineral absorption 💬 | [4] 6 6, 13, 290, 299 |
651 | Lucen | - | - | - | - | [1] 113 113 |
652 | Lucentis | [1] Ranibizumab Ranibizumab | [1] D05697
D05697
| [1] VEGFA VEGFA 💬 | [24] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [1] 166 166 |
653 | Lucerastat | [1] Lucerastat Lucerastat | [1] D11439
D11439
| [1] UGCG UGCG 💬 | [2] Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 |
654 | Lucinactant | [1] Lucinactant Lucinactant | [1] D04792
D04792
| - | - | [1] 299 299 |
655 | Lucinactant first | [1] Lucinactant Lucinactant | [1] D04792
D04792
| - | - | [1] 299 299 |
656 | Lucrin | - | - | - | - | [1] 67 67 |
657 | Lulizumab Pegol | [1] Lulizumab pegol Lulizumab pegol | - | - | - | [1] 49 49 |
658 | LUM | - | - | - | - | [1] 299 299 |
659 | LUM-201 | - | - | - | - | [1] 78 78 |
660 | LUM/IVA | - | - | - | - | [1] 299 299 |
661 | LUM/IVA fixed-dose combination | - | - | - | - | [1] 299 299 |
662 | LUM001 | - | - | - | - | [4] 93 93, 94, 297, 338 |
663 | LUM001 (Maralixibat) | [1] Maralixibat Maralixibat | [1] D10951
D10951
| [2] SLC10A1 SLC10A1, SLC10A2 💬 | [2] Bile secretion Bile secretion, Hepatitis B 💬 | [1] 297 297 |
664 | LUMACAFTOR | [1] Lumacaftor Lumacaftor | [1] D10134
D10134
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
665 | Lumacaftor / ivacaftor | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] D09916
D09916
,
D10134
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
666 | Lumacaftor plus Ivacaftor | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] D09916
D09916
,
D10134
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
667 | Lumacaftor Plus Ivacaftor Combination | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] D09916
D09916
,
D10134
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
668 | Lumacaftor, Ivacaftor Drug Combination | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] D09916
D09916
,
D10134
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
669 | Lumacaftor-ivacaftor | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] D09916
D09916
,
D10134
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
670 | Lumacaftor-Ivacaftor treatment | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] D09916
D09916
,
D10134
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
671 | Lumacaftor/Ivacaftor | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] D09916
D09916
,
D10134
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
672 | Lumacaftor/ivacaftor 100mg/125mg tablets | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] D09916
D09916
,
D10134
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
673 | Lumacaftor/ivacaftor 200mg/125mg | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] D09916
D09916
,
D10134
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
674 | Lumacaftor/ivacaftor 200mg/125mg tablets | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] D09916
D09916
,
D10134
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
675 | Lumacaftor/ivacaftor 200mg/83mg tablet | [2] Ivacaftor Ivacaftor, Lumacaftor | [2] D09916
D09916
,
D10134
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
676 | LUMASIRAN | [1] Lumasiran Lumasiran | [1] D11925
D11925
| [1] HAO1 HAO1 💬 | [4] Carbon metabolism Carbon metabolism, Glyoxylate and dicarboxylate metabolism, Metabolic pathways, Peroxisome 💬 | [1] 234 234 |
677 | Lumbar epidural injection | - | - | - | - | [1] 70 70 |
678 | Lumbar Interbody Fusion with Autograft | [1] Iron polymaltose Iron polymaltose | - | - | - | [1] 70 70 |
679 | Lumbar Interbody Fusion with NeoFuse | [1] Iron polymaltose Iron polymaltose | - | - | - | [1] 70 70 |
680 | Lumbar interlaminar epidural steroid injection | - | - | - | - | [1] 70 70 |
681 | Lumbar Puncture | - | - | - | - | [6] 6 6, 13, 19, 96, 97, 127 |
682 | Lumentin 44 | - | - | - | - | [1] 96 96 |
683 | Lumiracoxib | [1] Lumiracoxib Lumiracoxib | [1] D03714
D03714
| [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
684 | Lumizyme | [1] Alglucosidase alfa Alglucosidase alfa | [1] D03207
D03207
| [1] GAA GAA 💬 | [4] Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | [1] 256 256 |
685 | Lumizyme® | [1] Alglucosidase alfa Alglucosidase alfa | [1] D03207
D03207
| [1] GAA GAA 💬 | [4] Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | [1] 256 256 |
686 | Lunasin | [1] Lunasine Lunasine | - | - | - | [1] 2 2 |
687 | Lunasin Regimen | [1] Lunasine Lunasine | - | - | - | [1] 2 2 |
688 | Lung Clearance Index | - | - | - | - | [1] 299 299 |
689 | Lung Spheroid Stem Cells 100 million | - | - | - | - | [1] 85 85 |
690 | Lung Spheroid Stem Cells 200 million | - | - | - | - | [1] 85 85 |
691 | Lung stem cells | - | - | - | - | [1] 85 85 |
692 | Luo-Fu-Shan Plaster | - | - | - | - | [1] 46 46 |
693 | Luphere depot 3.75mg(Leuprolide acetate 3.75mg) | [2] Acetate Acetate, Leuprolide | [1] D00989
D00989
| [1] GNRHR GNRHR 💬 | [2] GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 |
694 | Lupron (leuprolide acetate) | [2] Acetate Acetate, Leuprolide | [1] D00989
D00989
| [1] GNRHR GNRHR 💬 | [2] GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 76 76 |
695 | Lupuzor | - | - | - | - | [1] 49 49 |
696 | Lusvertikimab | - | - | - | - | [1] 97 97 |
697 | Lutein | [1] Lutein Lutein | - | - | - | [3] 13 13, 90, 164 |
698 | Lutein (10 or 30 mg/day) capsules | [1] Lutein Lutein | - | - | - | [1] 90 90 |
699 | Lutein plus Zeaxanthin | [2] Lutein Lutein, Zeaxanthin | - | - | - | [1] 164 164 |
700 | Luteinizing hormone | [1] Luteinizing hormone Luteinizing hormone | - | - | - | [1] 254 254 |
701 | Luteinizing hormone-releasing factor | [1] Luteinizing hormone Luteinizing hormone | - | - | - | [1] 254 254 |
702 | LUTENYL | - | - | - | - | [1] 13 13 |
703 | LX1606 | - | - | - | - | [1] 97 97 |
704 | LX3305 | - | - | - | - | [2] 46 46, 161 |
705 | LX3305 250 mg capsule | - | - | - | - | [1] 161 161 |
706 | LX3305 Dihydrate | - | - | - | - | [1] 46 46 |
707 | LX3305 high dose | - | - | - | - | [1] 46 46 |
708 | LX3305 low dose | - | - | - | - | [1] 46 46 |
709 | LX3305 mid dose | - | - | - | - | [1] 46 46 |
710 | LY03003 | - | - | - | - | [1] 6 6 |
711 | LY03003 ( Rotigotine, extended-release microspheres) | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
712 | LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection) | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
713 | LY03003( the name of rotigotine) | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
714 | LY03003(Rotigotine,extended-release microspheres) | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
715 | LY03009 F1 | - | - | - | - | [1] 6 6 |
716 | LY03009 F2 | - | - | - | - | [1] 6 6 |
717 | LY03009 F3 | - | - | - | - | [1] 6 6 |
718 | LY03009 F4 | - | - | - | - | [1] 6 6 |
719 | LY2127399 | - | - | - | - | [3] 13 13, 46, 49 |
720 | LY2127399 (Tabalumab) | [1] Tabalumab Tabalumab | [1] D10083
D10083
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 46 46 |
721 | LY2189102 | - | - | - | - | [1] 46 46 |
722 | LY2439821 | - | - | - | - | [3] 46 46, 107, 271 |
723 | LY248686 | - | - | - | - | [1] 13 13 |
724 | LY300164 | - | - | - | - | [1] 6 6 |
725 | LY3009104 | - | - | - | - | [6] 46 46, 49, 50, 93, 107, 325 |
726 | LY3074828 | - | - | - | - | [3] 37 37, 96, 97 |
727 | LY3090106 | - | - | - | - | [1] 53 53 |
728 | LY3090106 - IV | - | - | - | - | [1] 46 46 |
729 | LY3090106 - SQ | - | - | - | - | [1] 46 46 |
730 | LY3154207 | - | - | - | - | [1] 6 6 |
731 | LY3337641 | - | - | - | - | [1] 46 46 |
732 | LY3337641 20 mg | - | - | - | - | [1] 46 46 |
733 | LY3337641 5 mg | - | - | - | - | [1] 46 46 |
734 | LY3361237 | - | - | - | - | [1] 49 49 |
735 | LY3462817 | - | - | - | - | [1] 46 46 |
736 | LY3471851 | - | - | - | - | [2] 49 49, 97 |
737 | LY450190 | - | - | - | - | [1] 86 86 |
738 | LYC-30937 | - | - | - | - | [1] 97 97 |
739 | LYC-30937-EC | - | - | - | - | [1] 97 97 |
740 | Lycium Barbarum | - | - | - | - | [1] 90 90 |
741 | Lym-X-Sorb powder | - | - | - | - | [1] 299 299 |
742 | Lymphocyte immune globulin | - | - | - | - | [1] 96 96 |
743 | Lymphoseek | [1] Tilmanocept Tilmanocept | - | - | - | [1] 46 46 |
744 | LymphoStat-B | - | - | - | - | [1] 49 49 |
745 | LymphoStat-B TM | - | - | - | - | [1] 49 49 |
746 | LymphoStat-B®, monoclonal anti-BLyS, LSB, BENLYSTA® | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 |
747 | Lyophilized etanercept powder(Yisaipu) | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 |
748 | Lyrica | [1] Pregabalin Pregabalin | [1] D02716
D02716
| [4] CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 | [7] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | [1] 298 298 |
749 | Lyrica® | - | - | - | - | [1] 298 298 |
750 | LYS | - | - | - | - | [1] 19 19 |
751 | LYS-GM101 | - | - | - | - | [1] 19 19 |
752 | LYS-SAF302 | - | - | - | - | [1] 19 19 |
753 | LYS006 | - | - | - | - | [1] 97 97 |
754 | Lysine | [1] Lysine Lysine | [1] D02304
D02304
| - | - | [4] 13 13, 97, 228, 299 |
755 | Lysine-D-Proline-Threonine | [4] D-Proline D-Proline, Lysine, Proline, Threonine | [3] D00035
D00035
,
D00041
,
D02304
| - | - | [1] 97 97 |
756 | Lysodase | - | - | - | - | [1] 19 19 |
757 | Lysomucil 10 % | - | - | - | - | [1] 299 299 |
758 | Lysosomal acid lipase, Esterase cholesterol (human gene LIPA), Lysosomal acid lipase (human gene LIPA) | [1] Cholesterol Cholesterol | [1] D00040
D00040
| - | - | [1] 19 19 |
759 | Lysosomal acid lipase, Esterase, cholesterol (human gene LIPA), Lysosomal acid lipase (human gene LIPA) | [1] Cholesterol Cholesterol | [1] D00040
D00040
| - | - | [1] 19 19 |
760 | LZRSE-Col7A1 Engineered Autologous Epidermal Sheets | - | - | - | - | [1] 36 36 |